Product Code: TIPRE00025127
The metabolomics services market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% during 2021-2028.
The emerging markets in regions such as the Middle East, Africa, and Asia Pacific are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on developing markets, such as India and China, owing to the huge populations, including a large number of people suffering from chronic diseases. With the rising production costs, healthcare companies are striving to produce sufficient revenues to meet the demands of their investors.
Consumer expectations from diagnostic processes are growing with advancements in biotechnology. Moreover, these developments are encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. Infectious disease testing, molecular oncology, and pharmacogenomics are among the high-potential segments in emerging countries. Various players in the industry have been investing significant shares of their revenues in R&D activities to develop better and advanced products and technologies for the healthcare sector. The Asia Pacific metabolomics services market is expected to grow at the fastest CAGR during the forecast period due to the presence of significant biopharmaceutical companies in countries such as Japan and the growing number of local companies in countries such as China and India. Further, the growing prevalence of cancer and other chronic diseases is likely to boost the market growth in the coming years.
The global metabolomics services market, based on service type, has been segmented into targeted metabolomics service, and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold the largest share of the market in 2021. Moreover, the targeted metabolomics service segment is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation.
The global metabolomics services market, based on application is segmented into pharmaceutical and biotechnology industry, agritech, environment. In 2021, the pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 21.6% during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); National Healthcare Service (NHS); Centers for Disease Control and Prevention (CDC); National Chronic Kidney Disease; National Center for Biotechnology Information; National Institute of Diabetes and Digestive and Kidney Diseases; United Nations (UN) Global Population Prospects; National Statistics Institute; and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the metabolomics services market.
Reasons to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metabolomics services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global metabolomics services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Metabolomics Services Market - By Service Type
- 1.3.2 Global Metabolomics Services Market - By Application
- 1.3.3 Global Metabolomics Services Market - By Geography
2. Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Metabolomics Services Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East And Africa PEST Analysis
- 4.2.5 South And Central America PEST Analysis
- 4.3 Experts Opinion
5. Metabolomics Services Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Incidences of Cancer
- 5.1.2 Increasing Adoption of Metabolomics and Investments by Market Players
- 5.2 Market Restraints
- 5.2.1 High Cost of Tools, Instruments, and Usage
- 5.3 Market Opportunities
- 5.3.1 Development Opportunities in Emerging Countries
- 5.4 Future Trends
- 5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
- 5.5 Impact Analysis
- 5.6 Opportunities for Contract Research (CR)
- 5.7 Opportunities for Supplies of Consumables
- 5.8 Opportunities for Commercialization of Disease Biomarkers
6. Metabolomics Services Market- Global Analysis
- 6.1 Global Metabolomics Services Market Revenue Forecast and Analysis
- 6.2 Global Metabolomics Services Market, By Geography - Forecast and Analysis
- 6.3 Market Positioning of Key Players
7. Global Metabolomics Services Market Revenue and Forecasts To 2028- by Service Type
- 7.1 Overview
- 7.2 Global Metabolomics Services Market, By Service Type 2021 & 2028 (%)
- 7.3 Targeted Metabolomics Service
- 7.3.1 Overview
- 7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 7.4 Untargeted Metabolomics Service
- 7.4.1 Overview
- 7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. Metabolomics Services Market Revenue and Forecasts To 2028 - Application
- 8.1 Overview
- 8.2 Global Metabolomics Services Market Share by Application 2021 & 2028 (%)
- 8.3 Pharmaceutical and Biotechnology Industry
- 8.3.1 Overview
- 8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.3.2.1 Biomarker Discovery
- 8.3.2.1.1 Overview
- 8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.3.2.2 Toxicological Testing
- 8.3.2.2.1 Overview
- 8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.3.2.3 Drug Discovery
- 8.3.2.3.1 Overview
- 8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.3.2.4 Others
- 8.3.2.4.1 Overview
- 8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.4 Agritech
- 8.4.1 Overview
- 8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
- 8.5 Environment
- 8.5.1 Overview
- 8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. Metabolomics Services Market Revenue and Forecasts to 2028 - Geographical Analysis
- 9.1 North America: Metabolomics Services Market
- 9.1.1 Overview
- 9.1.2 North America: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.3 North America: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
- 9.1.4 North America: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
- 9.1.4.1 North America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
- 9.1.5 North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
- 9.1.5.1 US: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.1 US: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.2 US: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
- 9.1.5.1.3 US: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
- 9.1.5.1.3.1 US: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
- 9.1.5.2 Canada: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.1 Canada: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.2 Canada: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
- 9.1.5.2.3 Canada: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
- 9.1.5.2.3.1 Canada: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
- 9.1.5.3 Mexico: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.1 Mexico: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.2 Mexico: Metabolomics Services Market, by Service Type, 2019-2028 (USD Million)
- 9.1.5.3.3 Mexico: Metabolomics Services Market, by Application, 2019-2028 (USD Million)
- 9.1.5.3.3.1 Mexico: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019-2028 (USD Million)
- 9.2 Europe: Metabolomics Services Market
- 9.2.1 Overview
- 9.2.2 Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.3 Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.4 Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.4.1 Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.2.5 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
- 9.2.5.1 Germany: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.1.1 Germany: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.1.2 Germany: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.1.3 Germany: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.2 France: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.2.1 France: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.2.2 France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.2.3 France: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.2.3.1 France: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.3 UK: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.3.1 UK: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.3.2 UK: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.3.3 UK: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.4 Italy: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.4.1 Italy: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.4.2 Italy: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.4.3 Italy: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.5 Spain: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.5.1 Spain: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.5.2 Spain: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.5.3 Spain: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.6 Rest of Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.6.1 Rest of Europe: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.6.2 Rest of Europe: Metabolomics Services Market, by Service Type - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.6.3 Rest of Europe: Metabolomics Services Market, by Application - Revenue and Forecast to 2028 (USD Million)
- 9.2.5.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3 Asia Pacific Metabolomics Services Market Revenue and Forecasts To 2028
- 9.3.1 Overview
- 9.3.2 Asia Pacific Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.3 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.4 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.4.1 Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
- 9.3.5.1 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.1.1 Overview
- 9.3.5.1.2 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.1.3 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.1.4 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.1.4.1 Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.2.1 Overview
- 9.3.5.2.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.2.3 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.2.4 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.2.4.1 . China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.3 India Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.3.1 Overview
- 9.3.5.3.2 India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.3.3 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.3.4 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.3.4.1 India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.4.1 Overview
- 9.3.5.4.2 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.4.3 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.4.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.4.4.1 South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.5 Australia: Metabolomics Services Market Revenue and Forecasts to 2028(US$ Mn)
- 9.3.5.5.1 Overview
- 9.3.5.5.2 Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.3.5.5.3 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.5.4 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.5.4.1 Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.6 Rest of Asia Pacific: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.6.1 Overview
- 9.3.5.6.2 Rest of Asia Pacific: Metabolomics Services Market - Revenue and Forecast to 2028 (USD Million)
- 9.3.5.6.3 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.3.5.6.4 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.3.5.6.4.1 Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.4 Middle East & Africa Metabolomics Services Market Revenue and Forecasts To 2028
- 9.4.1 Overview
- 9.4.2 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.3 Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.4.4.1 Middle East & Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.4.5 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
- 9.4.5.1 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.1.1 Overview
- 9.4.5.1.2 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.1.3 UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.4.5.1.4 UAE: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.4.5.1.4.1 UAE: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.4.5.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.2.1 Overview
- 9.4.5.2.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.2.3 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.4.5.2.4 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.4.5.2.4.1 Saudi Arabia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.4.5.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.3.1 Overview
- 9.4.5.3.2 South Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.3.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.4.5.3.4.1 South Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.4.5.4 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.4.1 Overview
- 9.4.5.4.2 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.4.5.4.3 Rest of Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.4.5.4.4.1 Rest of Middle East and Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.5 South And Central America Metabolomics Services Market Revenue and Forecasts To 2028
- 9.5.1 Overview
- 9.5.2 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.5.3 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
- 9.5.4 South and Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
- 9.5.4.1 South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.5.5 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
- 9.5.5.1 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.5.5.1.1 Overview
- 9.5.5.1.2 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.5.5.1.3 Argentina Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
- 9.5.5.1.4 Argentina: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.5.5.1.4.1 Argentina: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.5.5.2.1 Overview
- 9.5.5.2.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
- 9.5.5.2.3 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
- 9.5.5.2.4 Brazil: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.5.5.2.4.1 Brazil: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3 Rest of South and Central America: Metabolomics Services Market- Revenue and Forecast to 2028 (USD Mn)
- 9.5.5.3.1 Overview
- 9.5.5.3.2 Rest of South and Central America: Metabolomics Services Market- Revenue and Forecast to 2028 (USD Mn)
- 9.5.5.3.3 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
- 9.5.5.3.4 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
- 9.5.5.3.4.1 Rest of South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry - Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Metabolomics Services Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 10.2 Europe: Impact Assessment of COVID-19 Pandemic
- 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
- 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Metabolomics Services Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies Done by the Companies in the Market, (%)
- 11.3 Organic Developments
- 11.4 Inorganic Developments
12. Company Profiles
- 12.1 BASF SE
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 TMIC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Creative Proteomics
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 BGI
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 RTI International
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Afekta Technologies Ltd.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Fred Hutchinson Cancer Research Center
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 West Coast Metabolomics Center
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Molecular You
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Metabolon, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 biocrates life sciences ag
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
- 12.12 Chenomx Inc.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
- 12.13 C-CAMP
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
- 12.14 metaSysX
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
- 12.15 MS-Omics
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms